company background image
MNOW

Mednow TSXV:MNOW Stock Report

Last Price

CA$0.55

Market Cap

CA$11.9m

7D

-5.2%

1Y

-74.4%

Updated

23 May, 2022

Data

Company Financials
MNOW fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

MNOW Stock Overview

Mednow Inc., a healthcare company, develops and operates a proprietary web application to facilitate the sale and distribution of prescription medications and the delivery of virtual care and telemedicine services in Canada.

Mednow Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Mednow
Historical stock prices
Current Share PriceCA$0.55
52 Week HighCA$2.90
52 Week LowCA$0.52
Beta0
1 Month Change-25.68%
3 Month Change-35.29%
1 Year Change-74.42%
3 Year Changen/a
5 Year Changen/a
Change since IPO-88.42%

Recent News & Updates

Shareholder Returns

MNOWCA Online RetailCA Market
7D-5.2%0.5%0.8%
1Y-74.4%-48.7%4.8%

Return vs Industry: MNOW underperformed the Canadian Online Retail industry which returned -48.7% over the past year.

Return vs Market: MNOW underperformed the Canadian Market which returned 4.8% over the past year.

Price Volatility

Is MNOW's price volatile compared to industry and market?
MNOW volatility
MNOW Average Weekly Movement12.0%
Online Retail Industry Average Movement13.8%
Market Average Movement9.8%
10% most volatile stocks in CA Market17.0%
10% least volatile stocks in CA Market4.4%

Stable Share Price: MNOW is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: MNOW's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20187Karim Nassarhttps://www.mednow.ca

Mednow Inc., a healthcare company, develops and operates a proprietary web application to facilitate the sale and distribution of prescription medications and the delivery of virtual care and telemedicine services in Canada. It also owns and operates three retail pharmacies located in British Columbia, Ontario, and Nova Scotia. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

Mednow Fundamentals Summary

How do Mednow's earnings and revenue compare to its market cap?
MNOW fundamental statistics
Market CapCA$11.86m
Earnings (TTM)-CA$17.75m
Revenue (TTM)CA$2.71m

4.4x

P/S Ratio

-0.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MNOW income statement (TTM)
RevenueCA$2.71m
Cost of RevenueCA$1.85m
Gross ProfitCA$864.02k
Other ExpensesCA$18.61m
Earnings-CA$17.75m

Last Reported Earnings

Jan 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.82
Gross Margin31.89%
Net Profit Margin-655.21%
Debt/Equity Ratio0.7%

How did MNOW perform over the long term?

See historical performance and comparison

Valuation

Is Mednow undervalued compared to its fair value and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


0.48x

Price to Book (PB) ratio

Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate MNOW's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate MNOW's fair value for valuation analysis.


Price To Earnings Ratio

PE vs Industry: MNOW is unprofitable, so we can't compare its PE Ratio to the North American Online Retail industry average.

PE vs Market: MNOW is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MNOW's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MNOW is good value based on its PB Ratio (0.5x) compared to the CA Online Retail industry average (1.3x).


Future Growth

How is Mednow forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


39.7%

Forecasted Retail industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Mednow has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Mednow performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-82.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: MNOW is currently unprofitable.

Growing Profit Margin: MNOW is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: MNOW is unprofitable, and losses have increased over the past 5 years at a rate of 82.8% per year.

Accelerating Growth: Unable to compare MNOW's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MNOW is unprofitable, making it difficult to compare its past year earnings growth to the Online Retail industry (-8.3%).


Return on Equity

High ROE: MNOW has a negative Return on Equity (-72.41%), as it is currently unprofitable.


Financial Health

How is Mednow's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: MNOW's short term assets (CA$20.5M) exceed its short term liabilities (CA$4.8M).

Long Term Liabilities: MNOW's short term assets (CA$20.5M) exceed its long term liabilities (CA$2.8M).


Debt to Equity History and Analysis

Debt Level: MNOW has more cash than its total debt.

Reducing Debt: Insufficient data to determine if MNOW's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MNOW has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: MNOW has less than a year of cash runway if free cash flow continues to reduce at historical rates of 77.4% each year


Dividend

What is Mednow current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate MNOW's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MNOW's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MNOW's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MNOW's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MNOW has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

0.8yrs

Average management tenure


CEO

Karim Nassar (39 yo)

2.08yrs

Tenure

CA$202,281

Compensation

Mr. Karim Nassar, MBA is the Co-founder at Mednow Inc. and its Chief Executive Officer since April 1, 2020. Mr. Nassar joined Care Group of Pharmacies in 2019 as Vice President of Digital Strategy where he...


CEO Compensation Analysis

Compensation vs Market: Karim's total compensation ($USD158.35K) is about average for companies of similar size in the Canadian market ($USD168.83K).

Compensation vs Earnings: Insufficient data to compare Karim's compensation with company performance.


Leadership Team

Experienced Management: MNOW's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Members

Experienced Board: MNOW's board of directors are considered experienced (3.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: MNOW insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Mednow Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Mednow Inc.
  • Ticker: MNOW
  • Exchange: TSXV
  • Founded: 2018
  • Industry: Internet and Direct Marketing Retail
  • Sector: Retail
  • Implied Market Cap: CA$11.863m
  • Shares outstanding: 21.57m
  • Website: https://www.mednow.ca

Number of Employees


Location

  • Mednow Inc.
  • 4484 Main Street
  • Vancouver
  • British Columbia
  • V5V 3R3
  • Canada

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/23 00:00
End of Day Share Price2022/05/19 00:00
Earnings2022/01/31
Annual Earnings2021/07/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.